Related Experiment Videos
Dystrophin assay in muscular dystrophies: an Indian experience
1Department of Neurology, All India Institute of Medical Sciences, New Delhi, India.
Background:
Dystrophin, a protein situated on the plasma membrane of skeletal muscle has been found to be abnormal in quality and quantity in patients with muscular dystrophies and may be useful in distinguishing between the different types. Experience with the technique has been limited to western countries.
Methods:
We used dystrophin staining with monoclonal NCL-DYS (rod domain) antidystrophin antibody using the avidin-biotin conjugate immunoperoxidase technique in 16 out of 20 patients with various types of muscular dystrophies at a large tertiary care medical centre in India.
Results:
The technique was unsuccessful in 4 cases. In the others the dystrophin staining pattern correlated well with the clinical diagnosis in 11 out of 16 patients. In the other 5 patients dystrophin assay helped to differentiate between Duchenne muscular dystrophy and the Becker muscular dystrophy in 2 patients suspected to have limb-girdle muscular dystrophy, it differentiated Duchenne muscular dystrophy from the Emery-Dreifuss muscular dystrophy and detected a manifest female carrier with Duchenne's dystrophy.
Conclusion:
Dystrophin staining may be useful in the differential diagnosis of patients with muscular dystrophies in India.
Insights
Dystrophin staining accurately diagnosed muscular dystrophies in most Indian patients. This method aids in differentiating various muscular dystrophy types, including Duchenne and Becker muscular dystrophy.
Area of Science:
- Neurology
- Biochemistry
Background:
- Abnormal dystrophin protein (quality/quantity) is characteristic of muscular dystrophies.
- Dystrophin analysis can differentiate between muscular dystrophy types.
- Previous dystrophin staining experience was limited to Western countries.
Purpose of the Study:
- To evaluate the utility of dystrophin staining in diagnosing muscular dystrophies in India.
- To assess the technique's ability to differentiate between various muscular dystrophy subtypes.
Main Methods:
- Dystrophin staining using monoclonal NCL-DYS (rod domain) antibody.
- Avidin-biotin conjugate immunoperoxidase technique employed.
- Study conducted on 16 patients with various muscular dystrophies in India.
Main Results:
- Successful dystrophin staining in 12 out of 16 patients.
- Staining patterns correlated with clinical diagnosis in 11 patients.
- Dystrophin assay differentiated Duchenne from Becker muscular dystrophy, identified Emery-Dreifuss muscular dystrophy, and detected a female carrier.
Conclusions:
- Dystrophin staining is a valuable tool for differential diagnosis of muscular dystrophies in the Indian population.
- The technique shows promise in distinguishing between different types of muscular dystrophies.